Insider Shareholders with Direct Ownership of Rocket Pharmaceuticals, Inc. (RCKT)
This section provides a comprehensive overview of the insiders with direct ownership of Rocket Pharmaceuticals, Inc. (RCKT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ROCKET PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gaurav Shah
CEO |
391,457 | 351,870 | 786,806 $2.39 Million | 25 |
May 20, 2025
Reduced 0.29%
|
| 335,929 | 47,634 | 441,927 $1.34 Million | 21 |
May 20, 2025
Reduced 0.17%
|
|
| 304,847 | 66,033 | 235,255 $715,175 | 10 |
May 20, 2025
Reduced 0.34%
|
|
|
Martin Wilson
General Counsel |
155,132 | 25,393 | 149,163 $453,455 | 14 |
May 20, 2025
Reduced 0.39%
|
|
Aaron Ondrey
Chief Financial Officer |
137,139 | 8,966 | 128,173 $389,645 | 4 |
Jul 03, 2025
Reduced 1.14%
|
| 87,758 | 18,638 | 69,140 $210,185 | 5 |
Oct 31, 2024
Reduced 4.26%
|
|
| 92,599 | 32,910 | 64,027 $194,642 | 35 |
May 20, 2025
Reduced 0.55%
|
|
| 54,734 | 0 | 54,734 $166,391 | 1 |
Jun 18, 2025
Added 31.12%
|
|
| 47,667 | 0 | 47,667 $144,907 | 1 |
Jun 18, 2025
Added 27.04%
|
|
| 44,220 | 0 | 44,220 $134,428 | 2 |
Jun 18, 2025
Added 40.42%
|
|
| 129,624 | 193,124 | 31,660 $96,246 | 6 |
Jun 18, 2025
Added 48.65%
|
|
| 30,000 | 0 | 30,000 $91,200 | 1 |
Jun 18, 2025
Added 50.0%
|
|
| 30,000 | 0 | 30,000 $91,200 | 1 |
Jun 18, 2025
Added 50.0%
|
|
| 30,000 | 0 | 30,000 $91,200 | 1 |
Jun 18, 2025
Added 50.0%
|
|
| 30,000 | 0 | 30,000 $91,200 | 1 |
Jun 18, 2025
Added 50.0%
|